Insider Trading activities of Eagle Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eagle Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Eagle Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Eagle Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is EGRX. The reporting company's CIK number is 827871.
The total value of stock buying since 2005 is $16,707,226.
The total value of stock sales since 2005 is $118,763,576.
The total value of stock option exercises since 2005 is $2,809,693.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Eagle Pharmaceuticals, Inc. (EGRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-03 0 $0 2,340 $126,219 115,444 $459,046
2017-12 0 $0 0 $0 2,340 $2,106
2017-08 20,750 $1,021,413 0 $0 0 $0
2017-06 350 $25,020 0 $0 0 $0
2017-05 455 $36,768 0 $0 0 $0
2017-04 0 $0 115,600 $9,912,422 54,180 $925,719
2017-03 6,511 $516,790 251,705 $20,771,838 14,125 $149,535
2017-01 0 $0 65,114 $5,545,108 0 $0
2016-12 0 $0 70,505 $5,344,885 60,505 $1,156,008
2016-11 0 $0 445,073 $33,229,756 5,987 $44,156
2016-09 0 $0 270,720 $18,067,028 0 $0
2016-08 0 $0 128,665 $7,914,215 0 $0
2016-04 0 $0 30,765 $1,249,981 0 $0
2016-03 1,000 $56,730 0 $0 0 $0
2016-02 0 $0 18,360 $1,262,433 0 $0
2016-01 0 $0 14,549 $1,256,087 0 $0
2015-12 0 $0 17,275 $1,555,675 0 $0
2015-11 0 $0 19,339 $1,252,877 0 $0
2015-10 0 $0 17,878 $1,269,606 0 $0
2015-09 0 $0 16,245 $1,242,823 0 $0
2015-08 0 $0 13,000 $1,246,375 0 $0
2015-07 0 $0 15,710 $1,250,280 0 $0
2015-06 0 $0 9,980 $814,368 9,980 $73,123
2015-03 0 $0 129,800 $5,451,600 0 $0
2014-04 3,950 $50,520 0 $0 0 $0
2014-02 999,999 $14,999,985 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Eagle Pharmaceuticals, Inc. insiders (EGRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-03-30 Tarriff Scott (CEO) Option Ex 113,104 4.04 456,940
2018-03-06 Flaum Sander A (Director) Sale 2,340 53.94 126,219
2018-03-05 Flaum Sander A (Director) Option Ex 2,340 .90 2,106
2017-12-18 Ratoff Steven B (Director) Option Ex 2,340 .90 2,106
2017-08-16 Meyers Pete A. (Chief Financial Officer) Buy 350 55.45 19,406
2017-08-09 Braunstein Douglas L (Director) Buy 20,400 49.12 1,002,007
2017-06-12 Meyers Pete A. (Chief Financial Officer) Buy 350 71.49 25,020
2017-05-19 Pernock David (Pres. & Chief Comm. Officer) Buy 255 79.69 20,320
2017-05-16 Pernock David (Pres. & Chief Comm. Officer) Buy 200 82.24 16,448
2017-04-25 Schreiber Alain (10% Owner) Sale 54,180 88.72 4,806,578
2017-04-25 Schreiber Alain (10% Owner) Option Ex 54,180 17.09 925,719
2017-04-03 Schreiber Alain (10% Owner) Sale 61,420 83.13 5,105,844
2017-03-31 Schreiber Alain (10% Owner) Sale 23,689 83.02 1,966,660
2017-03-30 Schreiber Alain (10% Owner) Sale 6,223 83.00 516,509
2017-03-29 Schreiber Alain (10% Owner) Sale 60,855 83.01 5,051,573
2017-03-28 Schreiber Alain (10% Owner) Sale 6,182 83.02 513,229
2017-03-27 Schreiber Alain (10% Owner) Sale 39,431 83.00 3,272,773
2017-03-23 Krill Steven L. (EVP & Chief Scientific Officer) Sale 7,025 82.06 576,492
2017-03-23 Krill Steven L. (EVP & Chief Scientific Officer) Option Ex 7,025 12.65 88,866
2017-03-23 Schreiber Alain (10% Owner) Sale 700 83.01 58,107
2017-03-22 Edlin Richard A. (Director) Buy 6,000 79.44 476,640
2017-03-22 Krill Steven L. (EVP & Chief Scientific Officer) Sale 7,100 80.09 568,639
2017-03-22 Krill Steven L. (EVP & Chief Scientific Officer) Option Ex 7,100 8.54 60,669
2017-03-21 Pernock David (Pres. & Chief Comm. Officer) Buy 61 83.98 5,122
2017-03-21 Schreiber Alain (10% Owner) Sale 500 83.10 41,550
2017-03-20 Schreiber Alain (10% Owner) Sale 51,883 82.10 4,259,594
2017-03-17 Schreiber Alain (10% Owner) Sale 38,997 82.01 3,198,143
2017-03-16 Schreiber Alain (10% Owner) Sale 9,120 82.08 748,569
2017-03-09 Pernock David (Pres. & Chief Comm. Officer) Buy 450 77.84 35,028
2017-01-04 Schreiber Alain (10% Owner) Sale 65,114 85.16 5,545,108
2016-12-23 Krill Steven L. (EVP & Chief Scientific Officer) Sale 5,127 78.61 403,018
2016-12-23 Krill Steven L. (EVP & Chief Scientific Officer) Option Ex 5,127 46.09 236,303
2016-12-22 Krill Steven L. (EVP & Chief Scientific Officer) Sale 5,126 76.78 393,569
2016-12-22 Krill Steven L. (EVP & Chief Scientific Officer) Option Ex 5,126 46.09 236,257
2016-12-21 Krill Steven L. (EVP & Chief Scientific Officer) Sale 10,252 77.17 791,198
2016-12-21 Krill Steven L. (EVP & Chief Scientific Officer) Option Ex 10,252 29.36 300,998
2016-12-20 Krill Steven L. (EVP & Chief Scientific Officer) Sale 10,000 76.69 766,880
2016-12-20 Krill Steven L. (EVP & Chief Scientific Officer) Option Ex 10,000 12.63 126,300
2016-12-19 Krill Steven L. (EVP & Chief Scientific Officer) Sale 10,000 75.61 756,070
2016-12-19 Krill Steven L. (EVP & Chief Scientific Officer) Option Ex 10,000 12.65 126,500
2016-12-15 Krill Steven L. (EVP & Chief Scientific Officer) Sale 10,000 74.79 747,900
2016-12-15 Krill Steven L. (EVP & Chief Scientific Officer) Option Ex 10,000 8.54 85,450
2016-12-13 Krill Steven L. (EVP & Chief Scientific Officer) Sale 10,000 73.62 736,160
2016-12-13 Krill Steven L. (EVP & Chief Scientific Officer) Option Ex 10,000 4.42 44,200
2016-12-13 Ratoff Steven B (Director) Sale 8,700 75.00 652,500
2016-12-12 Ratoff Steven B (Director) Sale 1,300 75.07 97,590
2016-11-30 Krill Steven L. (EVP & Chief Scientific Officer) Sale 5,787 80.00 462,960
2016-11-30 Krill Steven L. (EVP & Chief Scientific Officer) Option Ex 5,787 7.33 42,401
2016-11-28 Flaum Sander A (Director) Sale 5,000 78.66 393,300
2016-11-23 Krill Steven L. (EVP & Chief Scientific Officer) Sale 200 80.00 16,000
2016-11-23 Krill Steven L. (EVP & Chief Scientific Officer) Option Ex 200 8.78 1,755
2016-11-11 Schreiber Alain (10% Owner) Sale 15,551 85.00 1,321,835
2016-11-10 Schreiber Alain (10% Owner) Sale 18,935 85.70 1,622,767
2016-11-09 Schreiber Alain (10% Owner) Sale 148,800 77.81 11,578,574
2016-11-07 Schreiber Alain (10% Owner) Sale 5,030 75.39 379,211
2016-11-04 Schreiber Alain (10% Owner) Sale 46,170 75.00 3,462,750
2016-11-02 Schreiber Alain (10% Owner) Sale 199,600 70.10 13,992,359
2016-09-30 Schreiber Alain (10% Owner) Sale 22,100 70.06 1,548,326
2016-09-29 Schreiber Alain (10% Owner) Sale 77,900 70.04 5,456,116
2016-09-21 Schreiber Alain (10% Owner) Sale 99,795 66.43 6,629,681
2016-09-08 Schreiber Alain (10% Owner) Sale 34,086 62.33 2,124,580
2016-09-07 Schreiber Alain (10% Owner) Sale 11,442 62.26 712,378
2016-09-06 Schreiber Alain (10% Owner) Sale 25,397 62.84 1,595,947
2016-08-24 Schreiber Alain (10% Owner) Sale 11,605 62.78 728,561
2016-08-23 Schreiber Alain (10% Owner) Sale 17,265 63.13 1,089,887
2016-08-17 Schreiber Alain (10% Owner) Sale 14,696 61.01 896,602
2016-08-16 Schreiber Alain (10% Owner) Sale 60,150 61.22 3,682,142
2016-08-15 Schreiber Alain (10% Owner) Sale 24,949 60.80 1,517,023
2016-04-01 Tarriff Scott (President and CEO) Sale 30,765 40.63 1,249,981
2016-03-15 Graves Michael (Director) Buy 1,000 56.73 56,730
2016-02-01 Tarriff Scott (President and CEO) Sale 18,360 68.76 1,262,433
2016-01-04 Tarriff Scott (President and CEO) Sale 14,549 86.33 1,256,087
2015-12-22 Flaum Sander A (Director) Sale 3,225 93.75 302,359
2015-12-01 Tarriff Scott (President and CEO) Sale 14,050 89.20 1,253,316
2015-11-02 Tarriff Scott (President and CEO) Sale 19,339 64.78 1,252,877
2015-10-01 Tarriff Scott (President and CEO) Sale 17,878 71.02 1,269,606
2015-09-01 Tarriff Scott (President and CEO) Sale 16,245 76.50 1,242,823
2015-08-03 Tarriff Scott (President and CEO) Sale 13,000 95.88 1,246,375
2015-07-01 Tarriff Scott (President and CEO) Sale 15,710 79.58 1,250,280
2015-06-16 Krill Steven L. (Chief Scientific Officer) Sale 9,980 81.60 814,368
2015-06-16 Krill Steven L. (Chief Scientific Officer) Option Ex 9,980 7.33 73,123
2015-03-20 Tarriff Scott (President and CEO) Sale 120,000 42.00 5,040,000
2015-03-20 Flaum Sander A (Director) Sale 9,800 42.00 411,600
2014-04-03 Ratoff Steven B (Director) Buy 3,950 12.79 50,520
2014-02-18 Proquest Management Llc (10% Owner) Buy 333,333 15.00 4,999,995
2014-02-18 Schreiber Alain (Director) Buy 333,333 15.00 4,999,995
2014-02-18 Moorin Jay (Director) Buy 333,333 15.00 4,999,995

Insider trading activities including stock purchases, stock sales, and option exercises of EGRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Eagle Pharmaceuticals, Inc. (symbol EGRX, CIK number 827871) see the Securities and Exchange Commission (SEC) website.